JPMorgan Chase & Co’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1
| Closed | -$5 | – | 6930 |
|
|
2023
Q3 | $5 | Hold |
1
| – | – | ﹤0.01% | 6408 |
|
|
2023
Q2 | $4 | Hold |
1
| – | – | ﹤0.01% | 5935 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6396 |
|
|
2022
Q4 | $0 | Sell |
1
-1
| -50% | – | ﹤0.01% | 6241 |
|
|
2022
Q3 | $0 | Buy |
2
+1
| +100% | – | ﹤0.01% | 6058 |
|
|
2022
Q2 | $0 | Sell |
1
-15
| -94% | – | ﹤0.01% | 6148 |
|
|
2022
Q1 | $0 | Buy |
16
+15
| +1,500% | – | ﹤0.01% | 6159 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 6090 |
|
|
2021
Q3 | $0 | Sell |
1
-32
| -97% | – | ﹤0.01% | 5895 |
|
|
2021
Q2 | $3K | Sell |
33
-1,770
| -98% | -$161K | ﹤0.01% | 5356 |
|
|
2021
Q1 | $239K | Buy |
1,803
+60
| +3% | +$7.95K | ﹤0.01% | 4386 |
|
|
2020
Q4 | $278K | Buy |
1,743
+1,494
| +600% | +$238K | ﹤0.01% | 4044 |
|
|
2020
Q3 | $25K | Buy |
249
+24
| +11% | +$2.41K | ﹤0.01% | 4451 |
|
|
2020
Q2 | $27K | Buy |
225
+23
| +11% | +$2.76K | ﹤0.01% | 4365 |
|
|
2020
Q1 | $16K | Sell |
202
-5
| -2% | -$396 | ﹤0.01% | 4400 |
|
|
2019
Q4 | $61K | Buy |
207
+1
| +0.5% | +$295 | ﹤0.01% | 4179 |
|
|
2019
Q3 | $37K | Buy |
206
+50
| +32% | +$8.98K | ﹤0.01% | 4350 |
|
|
2019
Q2 | $62K | Buy |
156
+19
| +14% | +$7.55K | ﹤0.01% | 4177 |
|
|
2019
Q1 | $64K | Sell |
137
-6
| -4% | -$2.8K | ﹤0.01% | 4150 |
|
|
2018
Q4 | $69K | Buy |
143
+13
| +10% | +$6.27K | ﹤0.01% | 4169 |
|
|
2018
Q3 | $89K | Buy |
130
+5
| +4% | +$3.42K | ﹤0.01% | 4158 |
|
|
2018
Q2 | $86K | Buy |
+125
| New | +$86K | ﹤0.01% | 4132 |
|